← Evidence map

ReviewCurrent treatment options in oncology2025

Second-Line Treatment in cholangiocarcinoma - Current State of the Art and Future Perspectives.

Michał Siwek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41102546